Skip to main content
Log in

Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The effects of cerivastatin on antiatherogenic properties of high-density lipoproteins were studied in patients with coronary heart disease and hyperlipidemia. Apart from hypolipidemic effects, cerivastatin changed the phospholipid composition of high-density lipoproteins and improved their cholesterol-acceptor properties. This effect was most pronounced in the serum from patients with low content of high-density lipoprotein cholesterol. These data indicate that cerivastatin modulates antiatherogenic properties of high-density lipoproteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. Assman, H. Schkiewer, G. Schmitz,et al., Clin. Chem.,29, 2026–2030 (1983).

    Google Scholar 

  2. Ph. J. Barter and K. A. Rye,Curr. Opin. Lipidol.,7, 82–87 (1996).

    Article  Google Scholar 

  3. D. Bolin and A. Jones,J. Biol. Chem.,271, 19,152–19,158 (1996).

    Google Scholar 

  4. P. Bovet, R. Darioli, A. Essinger,et al., Atherosclerosis,80, 41–47 (1989).

    Article  PubMed  CAS  Google Scholar 

  5. M. de la Llera Moya, V. Atger, J. L. Paul,et al., Arterioscler. Thromb.,14, 1056–1065 (1994).

    PubMed  Google Scholar 

  6. R. A. Demel, J. W. Jansen, P. W. Dijek,et al., Biochem. Biophys. Acta,465, 1–10 (1977).

    Article  PubMed  CAS  Google Scholar 

  7. I. Folch and M. J. Lees,J. Biol. Chem.,226, 497–509 (1957).

    PubMed  CAS  Google Scholar 

  8. N. Fournier, M. de la Llera Moya,et al., J. Lipid. Res.,37, 1704–1711 (1996).

    Google Scholar 

  9. I. J. Holme,Circulation,82, 1916–1924 (1990).

    PubMed  CAS  Google Scholar 

  10. F. Kunz, C. Pechlaner, R. Erhart,et al., Arterioscler. Thromb.,14, 1146–1150 (1994).

    PubMed  CAS  Google Scholar 

  11. H. M. Laboda, J. M. Glick, and M. C. Phillips,Biochem. Biophys. Acta,876, 233–242 (1986).

    PubMed  CAS  Google Scholar 

  12. E. A. Stein,Drugs,56, Suppl. 1, 25–31 (1998).

    Article  PubMed  CAS  Google Scholar 

  13. A. Svannborg and L. Svennercholm,Acta Med. Scand.,169, 43–45 (1961).

    Article  Google Scholar 

  14. V. E. Vaskovsky, E. Y. Kostetsky, and J. M. Vasendin,J. Chromatogr.,114, 129–141 (1975).

    Article  PubMed  CAS  Google Scholar 

  15. C. J. Vaughan, M. B. Murphy, and B. M. Buckley,Lancet,348, 1079–1082 (1996).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 130, No. 10, pp. 433–436, October, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozerova, I.N., Jeevan, D.M., Serdyuk, A.P. et al. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia. Bull Exp Biol Med 130, 983–985 (2000). https://doi.org/10.1007/BF02682045

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02682045

Key Words

Navigation